Outcome Capital Further Bolsters Its Platform with the Addition of Jaison Ellis

Appointment of Jaison Ellis as Managing Director Strengthens Outcome’s Capabilities

BOSTON--(BUSINESS WIRE)--Outcome Capital, LLC, a highly specialized life sciences and healthcare advisory and investment banking firm, today announced that Jaison Ellis has joined the firm as a Managing Director, based in Charlotte, NC. The firm continues to expand its life sciences and healthcare practices through its unique, market-aligned, strategy-driven platform, delivering mergers and acquisitions, partnerships, and strategic advisory services.

“I’m delighted to join such a distinguished and high-quality team of professionals and excited to further Outcome’s vital work of helping clients achieve their strategic goals amidst a rapidly evolving healthcare landscape with vast opportunities for value creation,” said Jaison Ellis.

Mr. Ellis is a seasoned investment banking professional with deep experience in investment banking and capital markets. He has originated and executed over $150 billion in M&A and capital raising transactions across biopharmaceuticals, pharma services, lab services, and other healthcare subsectors. He is widely regarded as a trusted and collaborative advisor to management teams, boards, and investors, providing guidance on a broad range of strategic transactions, including sales, divestitures, mergers, acquisitions, and recapitalizations.

Dr. Oded Ben-Joseph, Managing Partner at Outcome Capital, commented, “We continue to expand our specialized, strategy-led execution model, enabling us to deliver premium outcomes for our clients as they navigate critical inflection points. Central to this effort is our unwavering focus on attracting and retaining top talent that consistently delivers superior value to our clients. Jaison’s diverse skill set and deep transaction experience make him an outstanding addition to our platform and will support our continued growth while reinforcing our core value proposition of combining sector expertise with transaction excellence.

Prior to joining Outcome, Mr. Ellis served as a Managing Director in the Healthcare Investment Banking group at Wells Fargo, where he worked since 2013. He previously held roles in the Mergers and Acquisitions group at BMO Capital Markets, as well as in the Alternative Investments and Financial Sponsors groups at Credit Suisse in New York.

Mr. Ellis earned a Bachelor of Arts in Business Administration with a concentration in Finance from Morehouse College, graduating summa cum laude.

About Outcome Capital
Outcome Capital is a highly specialized life sciences and healthcare advisory and investment banking firm providing innovative companies with a value-added, market-aligned approach to mergers and acquisitions, partnering, and corporate finance. The firm leverages its proven “strategy-led execution” approach to value enhancement, assisting management teams and boards in navigating complex financial and corporate markets to achieve optimal outcomes. Outcome’s multidisciplinary team—comprised of former CEOs, business development executives, venture capitalists, PhD- and MD-level scientists and clinicians, and experienced commercialization experts—brings deep scientific, operational, strategic, and transactional expertise across the healthcare value chain to help propel innovation from bench to bedside.